
Voglolysis 0.2mg Tablet
Marketer
Jrb Lifesciences Private Limited
Salt Composition
Voglibose (0.2mg)
Overview Voglolysis 0.2mg Tablet
Glycemicontrol 0.2mg tablets are prescribed for managing type 2 diabetes. This medication assists in regulating elevated blood glucose post-meal. It's indicated when dietary modifications and other comparable therapies prove insufficient in controlling hyperglycemia. Glycemicontrol 0.2mg tablets should be administered immediately prior to meals. Your physician will determine the appropriate dosage and frequency to optimize blood sugar control. Discontinuing this medication abruptly without medical consultation is strongly discouraged, as it may lead to dangerously high blood sugar levels and potentially severe complications such as renal impairment or vision loss. This medication forms one component of a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Closely monitor your blood glucose levels throughout treatment. Commonly reported side effects include intestinal gas, abdominal discomfort, appetite suppression, constipation, and diarrhea. Report any persistent or bothersome side effects to your doctor. While Glycemicontrol 0.2mg tablets alone do not typically cause hypoglycemia, concurrent use with other antidiabetic agents (particularly insulin or sulfonylureas) may increase this risk. Treat hypoglycemic episodes with plain glucose; sucrose is ineffective in this context. Inform your doctor of any pre-existing liver or kidney conditions before commencing treatment. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., ulcerative colitis or Crohn's disease). Pregnant or lactating individuals should seek medical advice prior to use. Always disclose all medications currently being taken to ensure medication safety. Limit alcohol consumption while using this medication to minimize the potential for hypoglycemia.
Uses of Voglolysis 0.2mg Tablet
Managing Type 2 Diabetes
Major Benefits of Voglolysis 0.2mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume the Voglolysis 0.2mg Tablet on an empty stomach.
Common Side effects of Voglolysis 0.2mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglolysis 0.2mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Voglolysis 0.2mg Tablet on an empty stomach.
How Voglolysis 0.2mg Tablet works:
Voglolysis 0.2mg tablets are used to manage diabetes. They work by blocking intestinal enzymes that digest complex carbohydrates, thus reducing postprandial blood glucose spikes.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglolysis 0.2mg Tablet with alcohol is contraindicated.
PregnancySAFE IF PRESCRIBED
The use of Voglolysis 0.2mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Voglolysis 0.2mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Voglolysis 0.2mg Tablets.
KidneyCAUTION
Patients with severe kidney impairment should use Voglolysis 0.2mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use 0.2mg Voglolysis tablets cautiously. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Voglolysis 0.2mg Tablet :
Omit any missed Voglolysis 0.2mg Tablet and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Voglolysis 0.2mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Alpha-glucosidase inhibitors |
